Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases

Rheumatoid arthritis (RA) and postmenopausal osteoporosis (PMOP) are common bone-immune diseases. The imbalance between helper (Th17) and regulatory T cells (Tregs) produced during differentiation of CD4+ T cells plays a key regulatory role in bone remodelling disorders in RA and PMOP. However, the...

Full description

Bibliographic Details
Main Authors: Xiaxia Wang, Bai Sun, Yujie Wang, Peng Gao, Jiayi Song, Weirong Chang, Zhipan Xiao, Yongbin Xi, Zhonghong Li, Fangyu An, Chunlu Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1333993/full
_version_ 1827369145821298688
author Xiaxia Wang
Bai Sun
Yujie Wang
Peng Gao
Jiayi Song
Weirong Chang
Zhipan Xiao
Yongbin Xi
Zhonghong Li
Fangyu An
Chunlu Yan
author_facet Xiaxia Wang
Bai Sun
Yujie Wang
Peng Gao
Jiayi Song
Weirong Chang
Zhipan Xiao
Yongbin Xi
Zhonghong Li
Fangyu An
Chunlu Yan
author_sort Xiaxia Wang
collection DOAJ
description Rheumatoid arthritis (RA) and postmenopausal osteoporosis (PMOP) are common bone-immune diseases. The imbalance between helper (Th17) and regulatory T cells (Tregs) produced during differentiation of CD4+ T cells plays a key regulatory role in bone remodelling disorders in RA and PMOP. However, the specific regulatory mechanism of this imbalance in bone remodelling in RA and PMOP has not been clarified. Identifying the regulatory mechanism underlying the Th17/Treg imbalance in RA and PMOP during bone remodelling represents a key factor in the research and development of new drugs for bone immune diseases. In this review, the potential roles of Th17, Treg, and Th17/Treg imbalance in regulating bone remodelling in RA and PMOP have been summarised, and the potential mechanisms by which probiotics, traditional Chinese medicine compounds, and monomers maintain bone remodelling by regulating the Th17/Treg balance are expounded. The maintenance of Th17/Treg balance could be considered as an therapeutic alternative for the treatment of RA and PMOP. This study also summarizes the advantages and disadvantages of conventional treatments and the quality of life and rehabilitation of patients with RA and PMOP. The findings presented her will provide a better understanding of the close relationship between bone immunity and bone remodelling in chronic bone diseases and new ideas for future research, prevention, and treatment of bone immune diseases.
first_indexed 2024-03-08T09:42:03Z
format Article
id doaj.art-aeaed86306dc4ea6bac7bd1d7ba57fa3
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T09:42:03Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-aeaed86306dc4ea6bac7bd1d7ba57fa32024-01-30T04:22:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-01-011510.3389/fimmu.2024.13339931333993Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseasesXiaxia Wang0Bai Sun1Yujie Wang2Peng Gao3Jiayi Song4Weirong Chang5Zhipan Xiao6Yongbin Xi7Zhonghong Li8Fangyu An9Chunlu Yan10School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaOrthopaedics Department, The No.2 People’s Hospital of Lanzhou, Lanzhou, Gansu, ChinaPathological Research Centre, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaTeaching Experiment Training Centre, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, ChinaRheumatoid arthritis (RA) and postmenopausal osteoporosis (PMOP) are common bone-immune diseases. The imbalance between helper (Th17) and regulatory T cells (Tregs) produced during differentiation of CD4+ T cells plays a key regulatory role in bone remodelling disorders in RA and PMOP. However, the specific regulatory mechanism of this imbalance in bone remodelling in RA and PMOP has not been clarified. Identifying the regulatory mechanism underlying the Th17/Treg imbalance in RA and PMOP during bone remodelling represents a key factor in the research and development of new drugs for bone immune diseases. In this review, the potential roles of Th17, Treg, and Th17/Treg imbalance in regulating bone remodelling in RA and PMOP have been summarised, and the potential mechanisms by which probiotics, traditional Chinese medicine compounds, and monomers maintain bone remodelling by regulating the Th17/Treg balance are expounded. The maintenance of Th17/Treg balance could be considered as an therapeutic alternative for the treatment of RA and PMOP. This study also summarizes the advantages and disadvantages of conventional treatments and the quality of life and rehabilitation of patients with RA and PMOP. The findings presented her will provide a better understanding of the close relationship between bone immunity and bone remodelling in chronic bone diseases and new ideas for future research, prevention, and treatment of bone immune diseases.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1333993/fullrheumatoid arthritispostmenopausal osteoporosistargeted therapyTh17/Treg equilibriumbone immunity
spellingShingle Xiaxia Wang
Bai Sun
Yujie Wang
Peng Gao
Jiayi Song
Weirong Chang
Zhipan Xiao
Yongbin Xi
Zhonghong Li
Fangyu An
Chunlu Yan
Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
Frontiers in Immunology
rheumatoid arthritis
postmenopausal osteoporosis
targeted therapy
Th17/Treg equilibrium
bone immunity
title Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
title_full Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
title_fullStr Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
title_full_unstemmed Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
title_short Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
title_sort research progress of targeted therapy regulating th17 treg balance in bone immune diseases
topic rheumatoid arthritis
postmenopausal osteoporosis
targeted therapy
Th17/Treg equilibrium
bone immunity
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1333993/full
work_keys_str_mv AT xiaxiawang researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT baisun researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT yujiewang researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT penggao researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT jiayisong researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT weirongchang researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT zhipanxiao researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT yongbinxi researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT zhonghongli researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT fangyuan researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases
AT chunluyan researchprogressoftargetedtherapyregulatingth17tregbalanceinboneimmunediseases